Observational studyThe Journal of antimicrobial chemotherapy2026
Factors influencing antibiotic use in confirmed viral respiratory tract infections.
Observational study in The Journal of antimicrobial chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe use of antibiotic therapy in confirmed viral respiratory tract infections is controversial, with discordance amongst guidelines.
objectivesWe evaluated antibiotic usage in patients admitted with confirmed influenza A, respiratory syncytial virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, as well as factors associated with their initiation and duration.
methodsThis was a prospective observational cohort study of patients admitted to a tertiary centre with PCR-confirmed viral respiratory tract infection. Patient characteristics, antibiotic use, choice, route and duration, as well as patient outcomes were measured. Clinical and microbiological factors related to the admission were recorded. Multivariate regression analyses were used to identify factors associated with antibiotic initiation and duration.
resultsThere were 241 admissions with confirmed viral respiratory tract infections over the 2025/26 winter period. Antibiotic therapy was commenced in 208 (86%) cases, with a median 7 days of therapy given. Additional cultures were taken from 159, with positive bacterial cultures in 35 (35/159, 22%). A requirement for supplemental oxygen (OR 4.61, P = 0.02) and increased C-reactive protein at admission (OR 1.03, P < 0.001) were associated with increased likelihood to commence antibiotics, while ongoing supplemental oxygen requirement (β coefficient 0.41, P = 0.005) was associated with increased duration of antibiotic therapy. Antibiotic duration was not influenced by bacterial culture results.
conclusionsWe demonstrate high rates of antibiotic usage in patients admitted with confirmed viral respiratory tract infection, and identify opportunities for improved antimicrobial stewardship.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.